Impact of labeling under the Pregnancy and Lactation Labeling Rule
Read MoreMAR 5-6 RCAC
Impact of labeling under the Pregnancy and Lactation Labeling Rule
Read MoreNov 7 RCAC
FDA’s draft Strategic Plan for Risk Communication and Health Literacy
Read MoreNOV 7 RCAC
FDA’s draft Strategic Plan for Risk Communication and Health Literacy
Read MoreNOV 7 RCAC
FDA’s draft Strategic Plan for Risk Communication and Health Literacy
Read MoreFEB 16-17 RCAC
Development in risk communication and possible approaches with FDA communications
Read MoreFEB 16-17 RCAC
Development in risk communication and possible approaches with FDA communications
Read MoreFEB 16-17 RCAC
Development in risk communication and possible approaches with FDA communications
Read MoreJUN 8-9 RCAC
Approaches to communicating information about fetal effects in product labeling for methadone or buprenorphine maintenance therapy for opioid addiction
Read MoreJUN 8-9 RCAC
Approaches to communicating information about fetal effects in product labeling for methadone or buprenorphine maintenance therapy for opioid addiction
Read MoreJUN 8-9 RCAC
Approaches to communicating information about fetal effects in product labeling for methadone or buprenorphine maintenance therapy for opioid addiction
Read MoreNOV 3-4 RCAC
Risk communication about eating adequate amounts of fish, while avoiding mercury
Read MoreNOV 3-4 RCAC
Risk communication about eating adequate amounts of fish, while avoiding mercury
Read MoreNOV 3-4 RCAC
Risk communication about eating adequate amounts of fish, while avoiding mercury
Read MoreNOV 3-4 RCAC
Risk communication about eating adequate amounts of fish, while avoiding mercury
Read More